Ask AI
ProCE Banner Series

Learn About A Frontline Treatment Option in Peripheral T-cell Lymphoma

This program is designed for healthcare professionals who treat patients with peripheral T-cell lymphoma (PTCL). The speaker will review a frontline treatment option for adults with previously untreated CD30-expressing PTCL, including the ECHELON-2 Phase 3 study design, efficacy and safety results, and dosing and administration considerations. Attendees will have the opportunity to ask questions and discuss how this information may apply to their clinical practice.

By the end of this program, attendees will be able to:

  1. Describe the ECHELON-2 Phase 3 study design, including the patient population, treatment arms, and key endpoints
  2. Review the efficacy results from ECHELON-2 in adults with previously untreated CD30-expressing PTCL
  3. Understand the safety profile, including the most common adverse reactions and how to manage them
  4. Identify dosing and administration considerations for incorporating this regimen into clinical practice

All Events

Learn About A Frontline Treatment Option in Peripheral T-cell Lymphoma

Upcoming Events

December

10

2026

12:15 PM - 1:00 PM Eastern Time (ET)

Virtual

Additional Info

Acknowledgement

Sponsored By

Pfizer Oncology